+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global HIV Diagnostics and Treatment Market 2019-2025

  • ID: 4871639
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • MORE
Global HIV Diagnostics and Treatment Market Size, Share & Trends Analysis Report by Test Type (Antibody Test, Viral Identification Assays, CD4 Testing, Viral Load Testing, and Early Infant Diagnostics), by Diagnostic Product (Kits and Reagents, and Instruments), by Treatment (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS), Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS), Integrase Inhibitors, and Others), and by End-User (Diagnostic Laboratory, Hospitals, Home Care Settings, Blood Bank, and Others) and Forecast 2019-2025.

The global HIV diagnostics and treatment market is expected to grow at a CAGR of 7.6% during the forecast period. The HIV impact on the immune system of human body weakens the patient’s defense system against any infections. It attacks and destroys white blood cell and T-helper cell. Progressively the immune system becomes vulnerable to any kind of infections. The market for HIV is growing considerably owing to increasing occurrence of HIV/AIDS infection around the globe. The government is taking initiatives for diagnosis and treatment, blood transfusions, and is significantly working on rising awareness regarding HIV/AIDS. The major factors that are responsible for the rising number of HIV infection includes lifestyle changes, unsafe injection drug usage and lack of awareness.

Geographically, the global aluminum foil market is classified into North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the global HIV diagnosis and treatment market due to the significant R&D activities for HIV/AIDS diagnosis and treatment. Regional government is taking initiatives for the ongoing diagnostic efforts for development of new treatment and products. Asia-Pacific is anticipated to grow at considerable pace in the global market during the forecast period. The partnerships among the western market players and the government in the region are major factors that are fueling the growth of HIV diagnosis and treatment market in the region.

The main players functioning in the global HIV diagnosis and treatment market include Bristol-Myers Squibb Co., Merck & Co., Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., bioMérieux SA, Gilead Sciences, Inc., Siemens AG, Sysmex Corp., and ViiV Healthcare. These players are playing a significant role in the growth of the HIV diagnosis and treatment market by providing various products and adopting several strategies such as a merger and acquisition, partnerships, collaboration, R&D; among others.

Research Methodology

The market study of the global HIV diagnostics and treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Forward looking statements from key market players
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for HIV diagnostics and treatment market players, pharmaceutical companies, research institutes, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
1. Global HIV Diagnostics and Treatment Market Research and Analysis by Test Type
2. Global HIV Diagnostics and Treatment Market Research and Analysis by Diagnostic Product
3. Global HIV Diagnostics and Treatment Market Research and Analysis by Treatment
4. Global HIV Diagnostics and Treatment Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the global HIV diagnostics & treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global HIV diagnostics and treatment market.
  • Insights about market determinants which are stimulating the global HIV diagnostic and treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Bristol-Myers Squibb Co.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Merck & Co., Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. GlaxoSmithKline PLC
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Gilead Sciences, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. ViiV Healthcare
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global HIV Diagnostics and Treatment Market by Test Type
5.1.1. Antibody Tests
5.1.1.1. HIV-1 Screening Tests
5.1.1.2. HIV-1 Antibody Confirmatory Tests
5.1.1.3. HIV-2 & Group O Diagnostics Tests
5.1.2. Viral Identification Assays
5.1.3. CD4 Testing
5.1.4. Viral Load Testing
5.1.5. Early Infant Diagnostics
5.2. Global HIV Diagnostics and Treatment Market by Diagnostics Products
5.2.1. Kits and Reagents
5.2.2. Instruments
5.3. Global HIV Diagnostics and Treatment Market by Treatment
5.3.1. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)
5.3.2. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS)
5.3.3. Integrase Inhibitors
5.3.4. Others (Protease Inhibitors (PIS))
5.4. Global HIV Diagnostics and Treatment Market by End-User
5.4.1. Diagnostics Laboratory
5.4.2. Hospitals
5.4.3. Blood Banks
5.4.4. Home Care Settings
5.4.5. Others (Academic and Research Institutes)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories
7.2. AbbVie Inc.
7.3. Becton, Dickinson and Co.
7.4. Bio-Rad Laboratories, Inc.
7.5. bioMérieux SA
7.6. Boehringer Ingelheim International GmbH
7.7. Bristol-Myers Squibb Co.
7.8. Cipla Inc.
7.9. F. Hoffmann-La Roche Ltd.
7.10. Gilead Sciences, Inc.
7.11. GlaxoSmithKline PLC
7.12. Hologic, Inc.
7.13. Johnson & Johnson Services, Inc.
7.14. Merck & Co., Inc.
7.15. Mylan N.V.
7.16. Pfizer Inc.
7.17. QIAGEN N.V.
7.18. Siemens AG
7.19. Sysmex Corp.
7.20. ViiV Healthcare
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Pfizer Inc.
  • QIAGEN N.V.
  • Siemens AG
  • Sysmex Corp.
  • ViiV Healthcare
Note: Product cover images may vary from those shown
Adroll
adroll